NESTOR DANTE VERANO: Open Payments
NPI 1679128144 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 10 payments from 7 companies in 2025. Trend: 2023 $737 · 2024 $1,038 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 2 | $129 |
| Novo Nordisk Inc | 1 | $109 |
| Amgen Inc. | 1 | $102 |
| Novartis Pharmaceuticals Corporation | 3 | $83 |
| Apellis Pharmaceuticals, Inc. | 1 | $39 |
| Calliditas Therapeutics US Inc. | 1 | $29 |
| AKEBIA THERAPEUTICS INC | 1 | $27 |
Products named: FUROSCIX, KRYSTEXXA, Empaveli, TARPEYO, Vanrafia, Vafseo.
Industry payments across IL — which companies pay providers there.
